NCT00069251已完成2 期
Bupropion for the Treatment of Methamphetamine Dependence
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 10
- 主要终点
- Severity addiction
研究概览
简要总结
The purpose of this study is to assess the efficacy and safety of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence
详细描述
A double-blind, placebo-controlled, parallel-group design study in which 100 subjects will be randomly assigned to placebo or bupropion for 12 weeks with follow-up assessments 4 weeks following treatment. Adaptive randomization will be used to balance treatment groups based on gender.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject must have methamphetamine dependence as determined by the DSM-IV diagnosis
- •Subject must be willing to comply with study procedures.
- •Ability to verbalize understanding of consent form, provide written consent, and verbalize willingness to complete study procedures
- •Be able to comply with protocol requirements
排除标准
- •Please contact site for more information.
结局指标
主要结局
Severity addiction
Methamphetamine use
次要结局
未报告次要终点
研究者
研究点 (10)
Loading locations...
相似试验
已完成
2 期
Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine DependenceMethamphetamine DependenceNCT00687713National Institute on Drug Abuse (NIDA)200
已完成
1 期
Buspirone as a Candidate Medication for Methamphetamine AbuseMethamphetamine DependenceMethamphetamine AbuseNCT01843205University of Kentucky9
已完成
2 期
Cocaine Use Reduction With BuprenorphineCocaine DependenceNCT01402492University of California, Los Angeles302
已完成
2 期
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2Cocaine-Related DisordersHeroin DependenceNCT00000211National Institute on Drug Abuse (NIDA)
已完成
2 期
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1Cocaine-Related DisordersHeroin DependenceNCT00000210National Institute on Drug Abuse (NIDA)